Comparison of serum levels of asymmetric dimethylarginine between patients who take two types of atypical anti psychotics

Background: Schizophrenia is associated with increased cardiovascular morbidity. Asymmetric dimethylarginine (ADMA) has been suggested as a cardiovascular biomarker. Treatment with atypical antipsychotics can increase some traditional risk factors of coronary artery disease. In addition to tradition...

Descripción completa

Detalles Bibliográficos
Autores principales: Safaei, Maryam, Akhondpoor Manteghi, Ali, Shahini, Najmeh, Mohammadpour, Amir Hooshang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iran University of Medical Sciences 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946932/
https://www.ncbi.nlm.nih.gov/pubmed/31934573
http://dx.doi.org/10.34171/mjiri.33.114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946932/
https://www.ncbi.nlm.nih.gov/pubmed/31934573
http://dx.doi.org/10.34171/mjiri.33.114

Ejemplares similares